Pegasus Asset Management Inc. Has $1.54 Million Stock Holdings in MiMedx Group, Inc. (NASDAQ:MDXG)

Pegasus Asset Management Inc. reduced its holdings in MiMedx Group, Inc. (NASDAQ:MDXG) by 4.2% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 160,000 shares of the company’s stock after selling 7,000 shares during the quarter. Pegasus Asset Management Inc.’s holdings in MiMedx Group were worth $1,539,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the stock. Allspring Global Investments Holdings LLC lifted its holdings in shares of MiMedx Group by 1.0% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 183,021 shares of the company’s stock valued at $1,082,000 after purchasing an additional 1,822 shares in the last quarter. Disciplined Growth Investors Inc. MN increased its position in shares of MiMedx Group by 0.8% during the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 355,387 shares of the company’s stock worth $2,100,000 after purchasing an additional 2,737 shares during the last quarter. SkyView Investment Advisors LLC lifted its stake in MiMedx Group by 30.0% in the third quarter. SkyView Investment Advisors LLC now owns 13,000 shares of the company’s stock valued at $77,000 after acquiring an additional 3,000 shares during the last quarter. Principal Financial Group Inc. increased its holdings in shares of MiMedx Group by 6.3% during the 3rd quarter. Principal Financial Group Inc. now owns 55,495 shares of the company’s stock worth $328,000 after acquiring an additional 3,292 shares during the last quarter. Finally, Orion Capital Management LLC grew its stake in MiMedx Group by 46.3% in the 3rd quarter. Orion Capital Management LLC now owns 11,700 shares of the company’s stock valued at $69,000 after buying an additional 3,700 shares during the last quarter. 79.15% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, StockNews.com cut MiMedx Group from a “strong-buy” rating to a “buy” rating in a report on Friday, November 8th. Six investment analysts have rated the stock with a buy rating, According to MarketBeat.com, MiMedx Group presently has a consensus rating of “Buy” and a consensus price target of $12.00.

MiMedx Group Trading Down 2.1 %

NASDAQ:MDXG opened at $8.22 on Wednesday. The firm has a 50-day moving average price of $8.92 and a two-hundred day moving average price of $7.62. The company has a debt-to-equity ratio of 0.10, a quick ratio of 3.53 and a current ratio of 4.10. MiMedx Group, Inc. has a 52 week low of $5.47 and a 52 week high of $10.14. The firm has a market cap of $1.21 billion, a price-to-earnings ratio of 14.95 and a beta of 1.94.

About MiMedx Group

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.